Western blot demonstrated that increased γ-H2AX was observed in MM cells in response to combination of CHI and BTZ compared with those cells treated with CHI or BTZ alone (Figure 4C), which was also validated by immunofluorescence staining of γ-H2AX in ARP-1 cells (Figure 4D). The gene discussed is H2AX; the disease is Miyoshi myopathy.